Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Another win for Novo in obesity as early oral med beats Wegovy
Novo Nordisk reported early results for a next-gen oral weight loss drug called amycretin, showing 13.1% weight loss after 12 weeks.
Annalee Armstrong
Mar 7, 2024 9:27am
Real-world data show Abbott’s CGM can help boost GLP-1 gains
Mar 6, 2024 11:16am
Novo Nordisk unveils new US hub as R&D investments soar
Feb 29, 2024 5:00am
Novo Nordisk sticks down $1.46B in biobucks for molecular glues
Feb 26, 2024 2:50pm
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
Novo Nordisk advances obesity pill as R&D spend skyrockets 35%
Jan 31, 2024 9:44am